These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1499733)
1. Is the cytosolic catalase induced by peroxisome proliferators in mouse liver on its way to the peroxisomes? Eriksson AM; Lundgren B; Andersson K; DePierre JW FEBS Lett; 1992 Aug; 308(2):211-4. PubMed ID: 1499733 [TBL] [Abstract][Full Text] [Related]
2. Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators. Crane DI; Zamattia J; Masters CJ Mol Cell Biochem; 1990 Aug; 96(2):153-61. PubMed ID: 2274048 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment. Hollinshead M; Meijer J Eur J Cell Biol; 1988 Aug; 46(3):394-402. PubMed ID: 3181162 [TBL] [Abstract][Full Text] [Related]
4. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk. Fahl WE; Lalwani ND; Reddy MK; Reddy JK Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505 [TBL] [Abstract][Full Text] [Related]
5. Induction of cytosolic and microsomal epoxide hydrolases in mouse liver by peroxisome proliferators, with special emphasis on structural analogues of 2-ethylhexanoic acid. Lundgren B; Meijer J; Birberg W; Pilotti A; Depierre JW Chem Biol Interact; 1988; 68(3-4):219-40. PubMed ID: 3214886 [TBL] [Abstract][Full Text] [Related]
6. In vitro translation of cytosolic and peroxisomal epoxide hydrolase and catalase on liver polyribosomes from untreated and clofibrate-treated C57B1/6 mice. Joste V; Meijer J FEBS Lett; 1989 May; 249(1):83-8. PubMed ID: 2721690 [TBL] [Abstract][Full Text] [Related]
7. Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate. Crane DI; Chen N; Masters C Mol Cell Biochem; 1988 May; 81(1):29-36. PubMed ID: 3173343 [TBL] [Abstract][Full Text] [Related]
8. Effects of hepatic peroxisome proliferators and 12-O-tetradecanoyl phorbol-13-acetate on catalase and other enzyme activities of embryonic cells in vitro. Mikalsen SO; Ruyter B; Sanner T Biochem Pharmacol; 1990 Feb; 39(3):527-35. PubMed ID: 2306265 [TBL] [Abstract][Full Text] [Related]
9. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. Leighton F; Coloma L; Koenig C J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406 [TBL] [Abstract][Full Text] [Related]
10. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators. Chen N; Crane DI Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):605-10. PubMed ID: 1575703 [TBL] [Abstract][Full Text] [Related]
11. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237 [TBL] [Abstract][Full Text] [Related]
12. Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver. Lundgren B; Bergstrand A; Karlsson K; DePierre JW Biochim Biophys Acta; 1990 Aug; 1035(2):132-8. PubMed ID: 2393663 [TBL] [Abstract][Full Text] [Related]
13. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771 [TBL] [Abstract][Full Text] [Related]
14. Induction of cytosolic and microsomal epoxide hydrolases and proliferation of peroxisomes and mitochondria in mouse liver after dietary exposure to p-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid. Lundgren B; Meijer J; DePierre JW Biochem Pharmacol; 1987 Mar; 36(6):815-21. PubMed ID: 3032197 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of the suppressive effect of nicardipine on peroxisome induction in rat liver. Itoga H; Tamura H; Watanabe T; Suga T Biochim Biophys Acta; 1990 Jan; 1051(1):21-8. PubMed ID: 2297537 [TBL] [Abstract][Full Text] [Related]
16. Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs. Farrell SO; Bieber LL Arch Biochem Biophys; 1983 Apr; 222(1):123-32. PubMed ID: 6838215 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Eacho PI; Lanier TL; Brodhecker CA Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515 [TBL] [Abstract][Full Text] [Related]
18. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Lalwani ND; Fahl WE; Reddy JK Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818 [TBL] [Abstract][Full Text] [Related]
19. Hepatic peroxisome proliferation in vitamin A-deficient mice without a simultaneous increase in peroxisomal acyl-CoA oxidase activity. Sohlenius AK; Reinfeldt M; Bäckström K; Bergstrand A; DePierre JW Biochem Pharmacol; 1996 Mar; 51(6):821-7. PubMed ID: 8602878 [TBL] [Abstract][Full Text] [Related]
20. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes. Moody DE; Reddy JK Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]